Outcome-Based Payment Schemes: What Outcomes Do Patients with Cancer Value?

ABSTRACT:

Background

Uncertainty about the benefits new cancer medicines will deliver in clinical practice risks delaying patient access to new treatment options in countries such as England, where the cost effectiveness of new medicines affects reimbursement decisions. Outcome-based payment (OBP) schemes, whereby the price paid for the drug is linked to patients' real-world treatment outcome(s) has been put forward as a mechanism to accelerate access. Although OBP schemes have generally focused on clinical outcomes to determine reimbursement, the degree to which these represent the outcomes that are important to patients is unclear.

Objective

To advance the application of OBP we ask, what outcomes do patients with cancer value (most) that might form a practical basis for OBP?

Meth

SUBMITTER: Lorgelly P 

PROVIDER: S-EPMC7478942 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature